Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. CCLD
CCLD logo

CCLD Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy CareCloud Inc (CCLD) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
3.620
1 Day change
-0.82%
52 Week Range
4.010
Analysis Updated At
2026/03/27
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

CareCloud Inc (CCLD) is not a strong buy for a beginner, long-term investor at this time. While the company has shown strong financial performance in its latest quarter, the lack of positive trading signals, neutral hedge fund and insider sentiment, and mixed analyst ratings suggest that it is better to hold off on investing in this stock for now.

Technical Analysis

The technical indicators show a bullish trend with SMA_5 > SMA_20 > SMA_200, a positive MACD histogram, and RSI in a neutral zone. However, the stock is trading near its resistance level (R1: 3.765) and has limited upside potential in the short term.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
2
Buy
10

Positive Catalysts

  • The company's Q4 financials show strong growth in revenue (up 21.90% YoY) and net income (up 15130.00% YoY), indicating operational improvements.

Neutral/Negative Catalysts

  • Analyst concerns about the company's acquisitions masking revenue declines and questionable decisions like purchasing an aircraft for client visits. No recent news or significant trading trends from hedge funds or insiders.

Financial Performance

In Q4 2025, CareCloud reported a revenue increase of 21.90% YoY to $34,423,000, net income growth of 15130.00% YoY to $1,523,000, and stable EPS growth. However, gross margin dropped by 2.04% YoY, which could indicate rising costs.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Roth Capital maintains a Neutral rating with a price target of $3.25, citing concerns about revenue declines and questionable acquisitions. No recent upgrades or positive changes in price targets.

Wall Street analysts forecast CCLD stock price to rise
3 Analyst Rating
Wall Street analysts forecast CCLD stock price to rise
2 Buy
1 Hold
0 Sell
Moderate Buy
Current: 3.650
sliders
Low
3.25
Averages
6.42
High
8
Current: 3.650
sliders
Low
3.25
Averages
6.42
High
8
Roth Capital
Richard Baldry
Neutral
maintain
$3.25
AI Analysis
2026-03-12
Reason
Roth Capital
Richard Baldry
Price Target
$3.25
AI Analysis
2026-03-12
maintain
Neutral
Reason
Roth Capital analyst Richard Baldry keeps a Neutral rating on CareCloud with a $3.25 price target following the company's Q4 report. CareCloud's results were "fair," but its acquisitions are masking underlying revenue declines, the analyst tells investors in a research note. Roth says the company was highly acquisitive in 2025, "oddly" including a disclosure in Q3 that is set up a subsidiary "for the purpose of acquiring an aircraft" which "will be used primarily for visiting current and prospective clients." The firm believes buying an aircraft "doesn't help."
ThinkEquity
NULL -> Buy
initiated
$8
2025-11-24
Reason
ThinkEquity
Price Target
$8
2025-11-24
initiated
NULL -> Buy
Reason
ThinkEquity initiated coverage of CareCloud with a Buy rating and $8 price target.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for CCLD
Unlock Now

People Also Watch